Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Granules India honoured with Golden Peacock Award for Sustainability

Ruchika Sharma15 Nov 2024 11:00 AM IST

Hyderabad: Granules India Limited, a pharmaceutical company, has announced that it has received the Golden Peacock Award for Sustainability....

AbbVie seeks USFDA nod for combination regimen of Venclexta, Acalabrutinib

AstraZeneca, Daiichi Sankyo submits Datopotamab deruxtecan new BLA for accelerated approval in US for lung cancer

Ruchika Sharma14 Nov 2024 3:15 PM IST

AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US for datopotamab deruxtecan...

CDSCO Panel Approves GSKs Proposal to Double Indian Patient Pool in Dostarlimab Trial

GSK Ojjaara approved in Canada for treatment of myelofibrosis in adults who have moderate to severe anemia

Ruchika Sharma14 Nov 2024 1:15 PM IST

Mississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or...

Eli Lilly Collaborates with Laekna to Develop Obesity Drug Targeting Muscle Preservation and Weight Loss

Ginkgo Bioworks advances collaboration with Merck to improve Biologics manufacturing

Ruchika Sharma14 Nov 2024 12:33 PM IST

Boston: Ginkgo Bioworks has announced the completion of the first milestone of a previously announced partnership with Merck, known as MSD outside of...

Granules India arm gets 1 USFDA observation for Hyderabad facility

Cipla gets 8 USFDA observations for Virgonagar facility

Ruchika Sharma14 Nov 2024 12:01 PM IST

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the Company's...

Natco Pharma net profit jumps 83 percent to Rs 676 crore in Q2

Ruchika Sharma13 Nov 2024 5:21 PM IST

Natco Pharma has announced an 83 percent on-year increase in its consolidated net profit for the September 2024 quarter, which rose to Rs 676 crore,...

Shanghai Pharma Vice President expresses hope for increased investment from Indian pharma cos in China

Ruchika Sharma13 Nov 2024 2:25 PM IST

Shanghai: Li Dongming, Vice President of Shanghai Pharmaceuticals, expressed hope on Tuesday for more investment from Indian pharmaceutical...

USFDA Suspends Ixchiq Chikungunya Vaccine License Citing Encephalitis Death, 20+ Serious Adverse Events

USFDA accepts Shilpa Medicare CDMO partner Unicycive NDA for Oxylanthanum Carbonate

Ruchika Sharma13 Nov 2024 12:13 PM IST

Karnataka: Shilpa Medicare CDMO partner Unicycive Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (USFDA) has...

Aurobindo Pharma in lead to acquire Zentiva for US 5.5 billion: ET Report

Aurobindo Pharma arm gets GMP certificate of compliance for biosimilars manufacturing facility from EMA

Ruchika Sharma13 Nov 2024 11:45 AM IST

Hyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has received a GMP certificate of...

Jubilant Pharmova to sell API business to wholly owned arm

Alembic Pharma bags USFDA nod for Ivabradine Tablets

Ruchika Sharma12 Nov 2024 4:05 PM IST

Vadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for...

USFDA grants Breakthrough Therapy Designation to Nipocalimab for treatment of adults with moderate-to-severe Sjögren's disease: JnJ

Ruchika Sharma12 Nov 2024 1:00 PM IST

Spring House: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has granted nipocalimab Breakthrough Therapy...

USFDA removes clinical hold on Novavax COVID Influenza combination, stand alone Influenza Phase 3 trial

Ruchika Sharma12 Nov 2024 11:00 AM IST

Gaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, has announced that the U.S. Food and...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok